Biotechnology-Europe Market Status and Trend Report 2013-2023

SKU ID :MI-12093392 | Published Date: 01-Apr-2018 | No. of pages: 131
Report Summary

Biotechnology-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in Europe, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges

The report segments the Europe Biotechnology market as:

Europe Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others

Europe Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others

Europe Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

  • PRICE
  • $3480
    $5980
    Buy Now

Our Clients